Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Poseida Therapeutics (PSTX)
NASDAQ:PSTX
Poseida Therapeutics (PSTX) Stock Price & Analysis
169 Followers
PSTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.82 - $8.82
Previous Close$3.28
Volume122.92K
Average Volume (3M)641.77K
Market Cap
$262.18M
Enterprise Value$90.07M
Total Cash (Recent Filing)$282.49M
Total Debt (Recent Filing)$88.75M
Price to Earnings (P/E)-3.0
Beta1.27
Next Earnings
May 10, 2023EPS Estimate
-$0.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.08
Shares Outstanding86,527,203
10 Day Avg. Volume661,375
30 Day Avg. Volume641,771
Standard Deviation0.19
R-Squared0.01
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.67
Price to Sales (P/S)2.11
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-9.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.69
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.73
Forecast
1Y Price Target
$15.33Price Target Upside405.94% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Poseida Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PSTX FAQ
What was Poseida Therapeutics’s price range in the past 12 months?
Poseida Therapeutics lowest stock price was $1.82 and its highest was $8.82 in the past 12 months.
What is Poseida Therapeutics’s market cap?
Currently, no data Available
When is Poseida Therapeutics’s upcoming earnings report date?
Poseida Therapeutics’s upcoming earnings report date is May 10, 2023 which is in 41 days.
How were Poseida Therapeutics’s earnings last quarter?
Poseida Therapeutics released its earnings results on Mar 09, 2023. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of $0.17 by -$0.56.
Is Poseida Therapeutics overvalued?
According to Wall Street analysts Poseida Therapeutics’s price is currently Undervalued.
Does Poseida Therapeutics pay dividends?
Poseida Therapeutics does not currently pay dividends.
What is Poseida Therapeutics’s EPS estimate?
Poseida Therapeutics’s EPS estimate is -$0.45.
How many shares outstanding does Poseida Therapeutics have?
Poseida Therapeutics has 86,527,210 shares outstanding.
What happened to Poseida Therapeutics’s price movement after its last earnings report?
Poseida Therapeutics reported an EPS of -$0.39 in its last earnings report, missing expectations of $0.17. Following the earnings report the stock price went down -18.812%.
Which hedge fund is a major shareholder of Poseida Therapeutics?
Among the largest hedge funds holding Poseida Therapeutics’s share is Aisling Capital Management LP. It holds Poseida Therapeutics’s shares valued at 6M.
---
Poseida Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.33 (405.94% Upside)
$15.33 (405.94% Upside)
Blogger Sentiment
Bullish
PSTX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 750.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.15%
12-Months-Change
Fundamentals
Return on Equity
-37.23%
Trailing 12-Months
Asset Growth
29.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Poseida Therapeutics
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumors.
---
Top 5 ETFs holding PSTX
Dimensional U.S. Equity ETF
$15.63K
Up to five ETFs with an Outperform Smart Score that hold PSTX. The ETFs are listed according to market value of PSTX within the ETF
---
Atara Biotherapeutics
―
Nkarta
―
Scholar Rock Holding
―
C4 Therapeutics
―
Lexicon Pharmaceuticals
―
---